Denosumab versus Risedronate in Glucocorticoid‐induced Osteoporosis: Final Results of a Twenty‐four–month Randomized, Double‐blind, Double‐dummy Trial|Citation only
Denosumab versus Risedronate in Glucocorticoid‐induced Osteoporosis: Final Results of a Twenty‐four–month Randomized, Double‐blind, Double‐dummy Trial|Citation only